Research And Markets Research And Markets
0 CHECKOUT

Sepsis - Pipeline Review, H2 2015

  • ID: 3492377
  • September 2015
  • 205 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • Adrenomed AG
  • Cell2B S.A.
  • Cognosci, Inc.
  • Huons Co., Ltd.
  • Novadiscovery SAS
  • Ribomic Inc.
  • MORE

Sepsis - Pipeline Review, H2 2015

Summary

The report ‘Sepsis - Pipeline Review, H2 2015’, provides an overview of the Sepsis’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Sepsis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Sepsis and special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updates following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Adrenomed AG
  • Cell2B S.A.
  • Cognosci, Inc.
  • Huons Co., Ltd.
  • Novadiscovery SAS
  • Ribomic Inc.
  • MORE

List of Tables

List of Figures

Introduction

REPORT COVERAGE

Sepsis Overview

Therapeutics Development

Pipeline Products for Sepsis - Overview

Pipeline Products for Sepsis - Comparative Analysis

Sepsis - Therapeutics under Development by Companies

Sepsis - Therapeutics under Investigation by Universities/Institutes

Sepsis - Pipeline Products Glance

Late Stage Products

Clinical Stage Products

Early Stage Products

Unknown Stage Products

Sepsis - Products under Development by Companies

Sepsis - Products under Investigation by Universities/Institutes

Sepsis - Companies Involved in Therapeutics Development

Adrenomed AG

Altor BioScience Corporation

Am-Pharma B.V.

Arch Biopartners, Inc.

Asahi Kasei Pharma Corp.

Biomedica Management Corporation

Cell2B S.A.

Chiesi Farmaceutici SpA

Chiome Bioscience, Inc.

Cilian AG

Cognosci, Inc.

Diomune S.L

Endacea, Inc.

Evec, Inc.

Huons Co., Ltd.

Immune Response BioPharma, Inc.

Immunethep, SA

ImmunNovative Developments SL

InflaRx GmbH

Integrated BioTherapeutics, Inc.

ISU ABXIS Co.,Ltd.

Lead Discovery Center GmbH

Navigen Pharmaceuticals, Inc.

Novadiscovery SAS

Ocata Therapeutics, Inc.

OncoImmune, Inc.

Opsona Therapeutics Limited

ProThera Biologics, LLC.

Ribomic Inc.

Silence Therapeutics Plc

Stemedica Cell Technologies, Inc.

Syntiron LLC

Takeda Pharmaceutical Company Limited

TiGenix NV

VBS Pharmaceuticals

XImmune AB

Sepsis - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Drug Profiles

3K3A-APC - Drug Profile

7-H9 - Drug Profile

AB-022 - Drug Profile

AcPepA - Drug Profile

adrecizumab - Drug Profile

Alpha B Crystalline - Drug Profile

ALT-836 - Drug Profile

AM/AMBP-1 - Drug Profile

Aspidasept - Drug Profile

Atu-111 - Drug Profile

bacterial sepsis vaccine - Drug Profile

BaxB-01 - Drug Profile

BaxG-03 - Drug Profile

BaxM-159 - Drug Profile

BRL-44408 - Drug Profile

BTZO-2 - Drug Profile

CAR Peptide - Drug Profile

ceftaroline fosamil - Drug Profile

CN-16 - Drug Profile

COG-133 - Drug Profile

Cx-611 - Drug Profile

Drug for Sepsis - Drug Profile

Drugs for Sepsis - Drug Profile

Drugs to Inhibit Aldose Reductase for Immunology, Ophthalmology, Infectious Disease, Metabolic and Respiratory Disorders - Drug Profile

Drugs to Inhibit Sialidase for Sepsis - Drug Profile

Escherichia coli vaccine - Drug Profile

EV-007156 - Drug Profile

Glyco-23 - Drug Profile

HBN-1 - Drug Profile

HBN-3 - Drug Profile

HBN-4 - Drug Profile

HU-003 - Drug Profile

IFX-1 - Drug Profile

ImmStem - Drug Profile

ImmuneSafe - Drug Profile

IND-005 - Drug Profile

IND-006 - Drug Profile

IR-999 - Drug Profile

ISU-201 - Drug Profile

Klebsiella pneumoniae vaccine - Drug Profile

L-97-1 - Drug Profile

LB-1148 - Drug Profile

LR-17 - Drug Profile

M-33 - Drug Profile

meropenem - Drug Profile

Mesenchymal Stem Cells - Drug Profile

Metablok - Drug Profile

Micselon - Drug Profile

Monoclonal Antibodies to Inhibit uPA for Infectious Disease and Respiratory Disorders - Drug Profile

Monoclonal Antibody 1 to Inhibit Aminoprocalcitonin for Sepsis, SIRS, Acute Lung Injury and Alzheimer's Disease - Drug Profile

Monoclonal Antibody 2 to Inhibit Aminoprocalcitonin for Sepsis, SIRS, Acute Lung Injury and Alzheimer's Disease - Drug Profile

Monoclonal Antibody for Pancreatic Cancer, Sepsis and Disseminated Intravascular Coagulation - Drug Profile

Monoclonal Antibody to Inhibit Aminoprocalcitonin for Sepsis, SIRS, Acute Lung Injury and Alzheimer's Disease - Drug Profile

Nanotherapeutics - Drug Profile

NAV-838 - Drug Profile

OPN-305 - Drug Profile

Peptide to Agonize GHSR-1a for Sepsis, Acute Radiation Syndrome and Acute Ischemic Stroke - Drug Profile

Polysaccharide for Sepsis - Drug Profile

Proteins to Inhibit Furin for Anthrax Intoxication and Sepsis - Drug Profile

RBM-005 - Drug Profile

Recombinant Enzyme to Replace Alkaline Phosphatase for Sepsis - Drug Profile

Recombinant Human Alkaline Phosphatase - Drug Profile

Recombinant Protein for Acute Lung Injury, Sepsis and Chronic Inflammation - Drug Profile

Recombinant Protein for Sepsis - Drug Profile

Recombinant Protein for Sepsis, Inflammatory bowel disease, Acute Kidney Injury, Acute radiation syndrome and Ischemic organ injury - Drug Profile

Recombinant Protein to Target Lipopolysaccharide for Sepsis - Drug Profile

SAN-101 - Drug Profile

Slit2N - Drug Profile

Small Molecule for Immunology, CNS, Cardiovascular and Infectious Disease - Drug Profile

Small Molecule to Inhibit DDAH1 for Sepsis - Drug Profile

Small Molecules for Inflammatory Diseases and Sepsis - Drug Profile

Small Molecules to Inhibit NET Formation for Sepsis and SLE - Drug Profile

staphylococcus aureus (bivalent) vaccine - Drug Profile

Stem Cell Therapy for Autoimmune Diseases - Drug Profile

Synthetic Peptide to Inhibit TREM-1 for Cancer and Infectious Diseases - Drug Profile

Synthetic Peptides for Immunology and Infectious Diseases - Drug Profile

Synthetic Peptides for Infectious Disease - Drug Profile

Synthetic Peptides for Inflammation and Infectious Disorders - Drug Profile

Synthetic Peptides for Sepsis, Bacterial and Fungal Infections - Drug Profile

Synthetic Peptides to Inhibit LPS for Bacterial and Viral Infections - Drug Profile

TF-0003 - Drug Profile

thrombomodulin alfa - Drug Profile

TRX-306 - Drug Profile

vancomycin hydrochloride - Drug Profile

Yersinia pestis vaccine - Drug Profile

Sepsis - Recent Pipeline Updates

Sepsis - Dormant Projects

Sepsis - Discontinued Products

Sepsis - Product Development Milestones

Featured News & Press Releases

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Number of Products under Development for Sepsis, H2 2015

Number of Products under Development for Sepsis - Comparative Analysis, H2 2015

Number of Products under Development by Companies, H2 2015

Number of Products under Development by Companies, H2 2015 (Contd..1)

Number of Products under Development by Companies, H2 2015 (Contd..2)

Number of Products under Development by Companies, H2 2015 (Contd..3)

Number of Products under Investigation by Universities/Institutes, H2 2015

Comparative Analysis by Late Stage Development, H2 2015

Comparative Analysis by Clinical Stage Development, H2 2015

Comparative Analysis by Early Stage Development, H2 2015

Comparative Analysis by Unknown Stage Development, H2 2015

Products under Development by Companies, H2 2015

Products under Development by Companies, H2 2015 (Contd..1)

Products under Development by Companies, H2 2015 (Contd..2)

Products under Development by Companies, H2 2015 (Contd..3)

Products under Investigation by Universities/Institutes, H2 2015

Products under Investigation by Universities/Institutes, H2 2015 (Contd..1)

Sepsis - Pipeline by Adrenomed AG, H2 2015

Sepsis - Pipeline by Altor BioScience Corporation, H2 2015

Sepsis - Pipeline by Am-Pharma B.V., H2 2015

Sepsis - Pipeline by Arch Biopartners, Inc., H2 2015

Sepsis - Pipeline by Asahi Kasei Pharma Corp., H2 2015

Sepsis - Pipeline by Biomedica Management Corporation, H2 2015

Sepsis - Pipeline by Cell2B S.A. , H2 2015

Sepsis - Pipeline by Chiesi Farmaceutici SpA, H2 2015

Sepsis - Pipeline by Chiome Bioscience, Inc., H2 2015

Sepsis - Pipeline by Cilian AG, H2 2015

Sepsis - Pipeline by Cognosci, Inc., H2 2015

Sepsis - Pipeline by Diomune S.L, H2 2015

Sepsis - Pipeline by Endacea, Inc., H2 2015

Sepsis - Pipeline by Evec, Inc., H2 2015

Sepsis - Pipeline by Huons Co., Ltd., H2 2015

Sepsis - Pipeline by Immune Response BioPharma, Inc., H2 2015

Sepsis - Pipeline by Immunethep, SA, H2 2015

Sepsis - Pipeline by ImmunNovative Developments SL, H2 2015

Sepsis - Pipeline by InflaRx GmbH, H2 2015

Sepsis - Pipeline by Integrated BioTherapeutics, Inc., H2 2015

Sepsis - Pipeline by ISU ABXIS Co.,Ltd., H2 2015

Sepsis - Pipeline by Lead Discovery Center GmbH, H2 2015

Sepsis - Pipeline by Navigen Pharmaceuticals, Inc., H2 2015

Sepsis - Pipeline by Novadiscovery SAS, H2 2015

Sepsis - Pipeline by Ocata Therapeutics, Inc., H2 2015

Sepsis - Pipeline by OncoImmune, Inc., H2 2015

Sepsis - Pipeline by Opsona Therapeutics Limited, H2 2015

Sepsis - Pipeline by ProThera Biologics, LLC., H2 2015

Sepsis - Pipeline by Ribomic Inc., H2 2015

Sepsis - Pipeline by Silence Therapeutics Plc, H2 2015

Sepsis - Pipeline by Stemedica Cell Technologies, Inc., H2 2015

Sepsis - Pipeline by Syntiron LLC, H2 2015

Sepsis - Pipeline by Takeda Pharmaceutical Company Limited, H2 2015

Sepsis - Pipeline by TiGenix NV, H2 2015

Sepsis - Pipeline by VBS Pharmaceuticals, H2 2015

Sepsis - Pipeline by XImmune AB, H2 2015

Assessment by Monotherapy Products, H2 2015

Number of Products by Stage and Target, H2 2015

Number of Products by Stage and Mechanism of Action, H2 2015

Number of Products by Stage and Route of Administration, H2 2015

Number of Products by Stage and Molecule Type, H2 2015

Sepsis Therapeutics - Recent Pipeline Updates, H2 2015

Sepsis - Dormant Projects, H2 2015

Sepsis - Dormant Projects (Contd..1), H2 2015

Sepsis - Dormant Projects (Contd..2), H2 2015

Sepsis - Dormant Projects (Contd..3), H2 2015

Sepsis - Discontinued Products, H2 2015

List of Figures

Number of Products under Development for Sepsis, H2 2015

Number of Products under Development for Sepsis - Comparative Analysis, H2 2015

Number of Products under Development by Companies, H2 2015

Number of Products under Investigation by Universities/Institutes, H2 2015

Comparative Analysis by Clinical Stage Development, H2 2015

Comparative Analysis by Early Stage Products, H2 2015

Assessment by Monotherapy Products, H2 2015

Number of Products by Top 10 Targets, H2 2015

Number of Products by Stage and Top 10 Targets, H2 2015

Number of Products by Top 10 Mechanism of Actions, H2 2015

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015

Number of Products by Top 10 Routes of Administration, H2 2015

Number of Products by Stage and Top 10 Routes of Administration, H2 2015

Number of Products by Top 10 Molecule Types, H2 2015

Number of Products by Stage and Top 10 Molecule Types, H2 2015

Note: Product cover images may vary from those shown
3 of 4

Adrenomed AG
Altor BioScience Corporation
Am-Pharma B.V.
Arch Biopartners, Inc.
Asahi Kasei Pharma Corp.
Biomedica Management Corporation
Cell2B S.A.
Chiesi Farmaceutici SpA
Chiome Bioscience, Inc.
Cilian AG
Cognosci, Inc.
Diomune S.L
Endacea, Inc.
Evec, Inc.
Huons Co., Ltd.
Immune Response BioPharma, Inc.
Immunethep, SA
ImmunNovative Developments SL
InflaRx GmbH
Integrated BioTherapeutics, Inc.
ISU ABXIS Co.,Ltd.
Lead Discovery Center GmbH
Navigen Pharmaceuticals, Inc.
Novadiscovery SAS
Ocata Therapeutics, Inc.
OncoImmune, Inc.
Opsona Therapeutics Limited
ProThera Biologics, LLC.
Ribomic Inc.
Silence Therapeutics Plc
Stemedica Cell Technologies, Inc.
Syntiron LLC
Takeda Pharmaceutical Company Limited
TiGenix NV
VBS Pharmaceuticals
XImmune AB

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

RELATED PRODUCTS from Db